EU Telemedicine Market Report

1
EU Telemedicine
Market
Telemedicine Market Size, And Share, By Type (Tele homes,
Tele hospitals, mHealth), By Clinical Service (Pathology,
Oncology, Cardiology, Surgery, Radiology, Other clinical
services), By Mode of Delivery (On Premise Delivery and
Cloud Delivery), and by Region (UK, Spain, Italy, Germany,
France and Rest of EU) and Forecast, 2019-2028
Sample Report

2
2 Confidential
Table of Content
1. EU Telemedicine Market Overview……………………………………..…………………………………………………………………………………………….…06
a. Market size and forecast
2. Market Growth Drivers & Restraints………………………………………………………………………...……………..............................................................08
a. Market Growth Drivers
i. Rising healthcare costs
ii. Technological innovations
iii. Increasing remote patient monitoring
iv. Growing burden of chronic diseases
b. Market Restraints
i. Legal & reimbursement issues
ii. High initial capital requirements and lack of physician support
3. EU Telemedicine Market Segmentation………………………………………………………………………………………………………………………………..15
a. By Type
i. Tele homes
ii. Tele hospitals
iii. mHealth (Mobile Health)

3
3 Confidential
Table of Content
b. By Clinical Services
i. Pathology
ii. Cardiology
iii. Surgery
iv. Radiology
v. Oncology
vi. Other clinical services
c. By Mode of Delivery
i. On-Premise Delivery
ii. Cloud-Based Delivery
d. By Region
i. Italy
ii. Germany
iii. Spain
iv. France
v. United Kingdom
vi. Rest of EU

4
4 Confidential
Table of Content
4. EU Telemedicine Market Share By Application……………………………………………………………………………………………………………….....……22
a. Market Share by Application
b. Key Findings
5. Competitive Landscape…………………………………………………………………………………………………………………………………………......…….24
a. EU Regional Presence in Telemedicine
b. Major companies in EU Telemedicine market
c. Insights & Forecast (Company market position analysis)
d. Competitive Landscape- Various EU startups leveraging telemedicine platforms
e. Key Company Profiles…………………………………………………………………………………………………………………………………………..……...28
f. Aerotel Medical Systems Ltd Company overview, Product & Services, Strategies & Financials
g. Allscripts Healthcare Solutions Company, Product & Services, Strategies & Financials
h. SHL Telemedicine Inc. Company, Product & Services, Strategies & Financials
i. Bio Telemetry Inc. Company, Product & Services, Strategies & Financials
j. IBM Corporation Company, Product & Services, Strategies & Financials
k. Resideo Technologies Inc. Company, Product & Services, Strategies & Financials
l. Medtronic PLC. Company, Product & Services, Strategies & Financials
m. Koninklijke Philips NV Company, Product & Services, Strategies & Financials
7. R&D initiatives by major companies…………………………………………………………………………………………………………………………………….45
a. R&D Expenditure By Major Companies
b. R&D Initiatives- Insights

5
5 Confidential
Table of Content
8. Access and Reimbursement Scenario………………………………………………………………………………………………………………………………….48
a. Region specific reimbursement scenario
b. Key market consideration in Telemedicine by region
9. Factors Driving Future Growth……………………………………………………………………………………………………………………………...……...……50
a. Key Industry Developments of Telemedicine market
b. Future Opportunities
10. Conclusion……………………………………………………………………………………………………………………………………………………………….….53

6
EU Telemedicine Market Overview

7
7 Confidential
EU Telemedicine Market- Market Size and Forecast Overview
The overall EU Telemedicine market in EU will experience sizable growth over the forecast period, increasing from $7.26 Bn in 2019 to
Over XX Bn in 2028 with a CAGR of 14.83%
EU Telemedicine Market Size ($Bn) (2019-2028) Key Insights
 The EU Telemedicine market accounted for
USD 7.26 Bn and is expected to register a
CAGR of 14.83% during the forecast period
 The market growth is attributed to factors like
increasing healthcare expenditure and
increasing preference for remote patient
monitoring
 Content
 Content
7.2

8
EU Market Growth Drivers & Restraints

9
9 Confidential
Market Growth Drivers & Restraints
Rising Healthcare
Costs
Growing Burden Of Chronic
Diseases
Increasing Remote
Patient Monitoring
Technological
Innovations
High Initial Capital
Requirements And Lack Of
Physical Support
Legal &
Reimbursement
Issues
Impact
Impact
Market
Drivers
Market
Restraints

10
10 Confidential
Market Growth Drivers
RISING HEALTHCARE COSTS
Healthcare has become more expensive as the population expanded—people get older and live longer. Therefore, 50% of
the increasing healthcare costs is attributed to increased costs for services, especially inpatient hospital care
Content
Among EU countries, Switzerland had the second-highest healthcare budget in 2019, with expenditures near $8,000 per
capita. Germany and Norway round out the top three, spending around $6,600 per capita each
Content

11
11 Confidential
TECHNOLOGICAL ADVANCEMENTS
Telemedicine and all types of mixed reality (MR), such as augmented reality (AR) and virtual reality (VR) go along very
well. MR technologies let clinicians get real-time information on patients’ vitals and experiences, which can improve the
accuracy of remote diagnostics
Content
Robotics has forayed into various fields of telemedicine. Tele-robots make remote patient monitoring, diagnosis, and virtual
care easier and more accurate
Content

12
12 Confidential
INCREASING REMOTE PATIENT MONITORING
The Remote Patient Monitoring Technology market has attracted significant investment in the past decade and is growing
at an extraordinary rate
In Netherlands, 51% of reduction in hospital cost was observed for COPD patients by using a Remote Telemonitoring App
It is expected to reach around 28 Bn euros by the end of 2023, this market is very attractive to many big name companies
that want to be ‘connected’ such as Qualcomm Life, Inc., OSI Systems, Inc., Philips Healthcare, Abbott Laboratories and
GE Healthcare among others
Content

13
13 Confidential
GROWING BURDEN OF CHRONIC DISEASES
Chronic diseases represent the major share of the burden of disease in EU, and are responsible for 86% of all deaths
Content
Over 50 Mn people in EU live with more than one chronic disease
Content

14
14 Confidential
Market Restraints
Legal & Reimbursement Issues
High Initial Capital Requirements And Lack Of
Physical Support
 Inadequate access to computing is a barrier to
telemedicine uptake for many developed
countries
 Equipment, transport, maintenance, and
training costs for local staff can be daunting for
countries with limited funding for the
implementation and maintenance of
telemedicine initiatives
 Physicians claim that telemedicine can never
replace an in-person examination of patients,
and its use may always be restricted only to
some special scenarios
 Content
 In EU, the laws suggests that telemedicine is
the responsibility of the national government
when undertaken within the borders of that
country and subject to legal constraints within
that country
 Many member states (MS) do not even have
legal instruments dealing specifically with
telemedicine in their own country, and only a
few have regulations or guidelines
 Content

15
EU Telemedicine Market Segmentation

16
16 Confidential
By Type
By Clinical
Servicey
By Mode Of
Delivery
By Region
 Tele homes
 Tele hospitals
 mHealth
(mHealth)
 Pathology
 Cardiology
 Surgery
 Radiology
 Oncology
 Other clinical
services
 On-Premise
Delivery
 Cloud-Based
Delivery
 Italy
 Germany
 Spain
 France
 United Kingdom
 Rest of EU

17
17 Confidential
Type 2019 2021 2023 2025 2028
CAGR
(%)
Tele homes XX XX XX XX XX XX
Tele
hospitals
XX XX XX XX XX XX
mHealth XX XX XX XX XX XX
TELEMEDICINE MARKET
Revenue in USD Mn, by Service, EU, 2019-2028
Key Insights
 Based on type, the Telemedicine market is bifurcated into Tele hospitals, Tele homes and m Health. The Tele home segment
held a significant growth in 2019, and expected to grow at 19.5% in EU
 A significant growth would be observed in this segment, because of an extensive adoption of remote patient monitoring
devices
Market Segmentation- By Type of Services

18
18 Confidential
 Pathology has witnessed the highest growth in 2019, and
expected to observe a soar rise during the forecast period
 Pathology segment enables the transfer of image-rich
data between distant locations for the purposes of
diagnosis, and research
 The surgery allows patient to reduce cost and travel time
associated with post-surgical treatment, which will boost
the segmental growth
 Content
 Content
Key Insights
Market Segmentation- By Clinical Services

19
19 Confidential
Market Segmentation- By Mode of delivery
 The Cloud Based Delivery has witnessed a significant
growth in 2019, and expected to capture a major share
during the forecast period
 One of the factors contributing to the market share is
supportive government initiatives to speed up
digitalization across all economic sectors
 For instance, the French government introduced Cloud
Strategy for the use of cloud computing by the
administration
 Content
 Content

20
20 Confidential
Market Segmentation- By Region
UK HealthCare Telecare functions similarly to an urgent care
clinic, making it easy for patients with acute-onset symptoms
to get expert care without leaving home
In the past years, Spain Telemedicine Market has observed a
decline in the market revenue share
In 2019, UK has witnessed a significant growth in the
Telemedicine Market due to increase in technology
advancements and use of smartphones
However, Spain Telemedicine Market will observe a
significant growth of 18.9% during the forecast period
Key Highlights

21
Telemedicine Market Share By Application

22
22 Confidential
Major Market Share By Application
 The Telemedicine by application indicates that Telemonitoring
and Teleconsulting comprised of nearly 50% of the market
share
 Telemonitoring alone accounted for approximately 22% share
in the year 2019, because of IoMT
 IoMT is accelerating digital transformation of healthcare using
a range of technologies aimed at diagnosing & monitoring
patients more effectively
 Content
Key Findings

24
24 Confidential
Competitive Landscape – EU Regional Presence

25
25 Confidential
Competitive Landscape- Market Sales of Major Players
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Koninklijke Philips
NV
5.56 XX XX XX XX XX XX XX XX XX
Medtronic PLC. 8.6 XX XX XX XX XX XX XX XX XX
Aerotel Medical
Systems
XX XX XX XX XX XX XX XX XX XX
Allscripts Healthcare
1.77 XX XX XX XX XX XX XX XX XX
SHL Telemedicine 0.041 XX XX XX XX XX XX XX XX XX
Bio Telemetry Inc. XX XX XX XX XX XX XX XX XX XX
IBM Corporation XX XX XX XX XX XX XX XX XX XX
Residio Technology XX XX XX XX XX XX XX XX XX XX
Major Market Sales of Telemedicine Companies in EU ($Bn)

26
26 Confidential
Competitive Landscape- Insights and Forecast
 Medtronic PLC, followed by IBM Corporation has the
highest market sales in the year 2019, and are expected
to exhibit the highest share during the forecast period
 Technological advancements currently going on in these
big health techs will drive the EU market further
 Technologies like the IBM Cloud, helps ensure one’s
solution’s scalability, and IBM Security solutions assist in
protecting patients’ information
 Content
Key Insights

27
27 Confidential
Competitive Landscape- Various EU startups leveraging telemedicine
platforms
Telemedico is a telemedicine platform for insurance and assistance companies from over 15 countries. Telemedico
is also integrating its solutions with various medical devices and implementing new technologies such as AI
(Poland)
(Luxembourg)
(France)
(Switzerland)
(Italy)
(Spain)
Docline is a telemedicine solution for insurance, healthcare providers and patients etc. Docline introduced an
innovative QR based e-prescriptions. The platform’s medical network consists of 1,500 doctors spanning over 25
specialties
DoctorsinItaly is a platform helping tourists find an English speaking doctor for both online & in person consultations.
The platform connects patients, practitioners, medical specialists, and mental health professionals
Derma2go is an online platform connecting patients with dermatologists who carry out on online diagnosis within 24
hours. Patients also receive a referral for an in person consultation and have medication delivered to homes
Doctena is a medical booking platform helping patients and doctors schedule their medical appointment in 6 EU
countries. The solution also enables doctors to manage reimbursements and issue prescriptions in the countries
where it is permitted
Consulib is a telemedicine platform available to all doctors in France without subscription or onboarding fees. The
platform also enables doctors to issue e-prescriptions, receive electronic medical records and manage payments.
More than 6000 doctors are registered on the startup’s platform

29
29 Confidential
Koninklijke Philips NV
Company Name: Koninklijke Philips NV
Year of Establishment: 1891
Headquarter: Amsterdam
Revenue: €19.535 Bn
Website: www.philips.com
Company Profile
 Philips was formerly one of the largest electronics companies
in the world, currently focused in the area of health technology,
with other divisions being divested
 Philips is organized into three main divisions: Personal Health,
Connected Care, and Diagnosis & Treatment
 In December 2020, Philips and Bio Telemetry, Inc., a leading
U.S.-based provider of remote cardiac diagnostics and
monitoring, announced that they had entered into a definitive
merger agreement
 In January 2021, Philips announced the acquisition of Capsule
Technologies, Inc., a provider of medical device integration and
data technologies for hospitals and healthcare organizations

30
30 Confidential
Koninklijke Philips NV
Revenues ($Bn), 2019-2028 Breakdown of net sales (%) by segment, 2019
Analysis
 The company is profiled for the financial year ended, 2028
 Content
Sample

31
31 Confidential
Medtronic PLC
Company Name: Medtronic PLC
Year of Establishment:
Headquarter:
Revenue:
Website:
Company Profile
Sample

32
32 Confidential
Medtronic PLC
Analysis
 Content
Sample

33
33 Confidential
Aerotel Medical Systems
Company Name: Aerotel Medical Systems
Headquarter:
Revenue:
Website:
Company Profile
Sample

34
34 Confidential
Aerotel Medical Systems
Analysis
 Content
Sample

35
35 Confidential
AllScripts Healthcare
Company Name: AllScripts Healthcare
Headquarter:
Revenue:
Website:
Company Profile
Sample

36
36 Confidential
AllScripts Healthcare
Analysis
 Content
Sample

37
37 Confidential
SHL Telemedicine
Company Name: SHL Telemedicine
Headquarter:
Revenue:
Website:
Company Profile
Sample

38
38 Confidential
SHL Telemedicine
Analysis
 Content
Sample

39
39 Confidential
Bio Telemetry Inc.
Company Name: Bio Telemetry Inc.
Headquarter:
Revenue:
Website:
Company Profile
Sample

40
40 Confidential
Bio Telemetry Inc.
Analysis
 Content
Sample

41
41 Confidential
IBM Corporation
Company Name: IBM Corporation
Headquarter:
Revenue:
Website:
Company Profile
Sample

42
42 Confidential
IBM Corporation
Analysis
 Content
Sample

43
43 Confidential
Resideo Technology
Company Name: Resideo Technology
Headquarter:
Revenue:
Website:
Company Profile
Sample

44
44 Confidential
Resideo Technology
Analysis
 Content
Sample

45
R&D Initiatives By Major Companies

46
46 Confidential
R&D Expenditure By Major Companies
Koninklijke Philips, followed by Medtronic PLC has the highest
contribution in the R&D expenditure for the telemedicine
The lowest R&D expenditure among the top players was
contributed by SHL Telemedicine. The expenditure reduced
from 2018 by 13%, which was attributed to capitalization of
development costs
Key Insights

47
47 Confidential
R&D Initiatives- Insights
 In 2019, Philips to acquire BioTelemetry,
Inc. for USD 72.00 per share; implied
enterprise value of USD 2.8 Bn
 Acquisition is a strong fit with a
combination of Philips’ leading patient
monitoring position in the hospital with
BioTelemetry’s leading cardiac
diagnostics and monitoring position
outside the hospital
 With 2019 sales of USD 439 Mn,
BioTelemetry annually monitors over 1
Mn cardiac patients remotely; its
portfolio includes wearable heart
monitors, AI-based data analytics and
services
 Teleclinic delivers security-rich
telemedicine services to patients
throughout Germany
 Teleclinic has launched its telemedicine
platform in a private IBM Cloud
environment and implements a security-
rich IBM Cloudant database layer
 Teleclinic provides 400,000 patients
across Germany with convenient digital
access to medical expertise and
anticipates powering intelligent health
predictions with IBM Watson technology
Acquired

48
Access And Reimbursement Scenario

49
49 Confidential
Access and reimbursement scenario- France
 The French Government and Parliament have been encouraging the development of telemedicine, and the reimbursement of
telemedicine acts by the social security administration through the National Health Insurance Program has developed over the past
ten years
 Content
 Telemedicine is allowed in France and governed by FCPH Art
 Telemedicine services can only be provided by healthcare
professionals or healthcare organizations such as hospitals
 It can only be performed with the informed consent of
patients
 It also must ensure the professional’s access to the personal
medical data of the patients which are necessary for his or
her treatment
General Reimbursement Environment
Key Market Access Considerations

50
50 Confidential
Access and reimbursement scenario- Spain
 In Spain, Both public and private sector cover telemedicine services
 Public reimbursement for telemedicine services is not covered in Spanish legislation, except for cross-border healthcare assistance
pursuant to Royal
 The Royal Decree states that the relevant public healthcare administration will reimburse the corresponding expenses. Private
healthcare insurance may reimburse some telemedicine services
 Content
 Telemedicine is generally allowed in Spain
 There are no expressly stated limitations or restrictions
applicable to telemedicine under Spanish law
 Each AACC healthcare authority has the autonomy to plan,
change and upgrade their healthcare infrastructures
 The Code of Medical Ethics of the General Council of
Medical Associations of Spain considers the practice of
medicine exclusively by means of internet unethical

51
51 Confidential
Access and reimbursement scenario- United Kingdom
 It is provided within the National Health Service (NHS), telemedicine will be free at the point of delivery, and funded by UK
taxpayers’ National Insurance contributions
 GPatHand is a free NHS funded service. There are no additional legal requirements for the telemedical industry in the UK
 Content
 Telemedicine is generally allowed in the UK
 Article 8 of the directive requires member states to control
whether healthcare professionals are respecting their
professional rules when offering these services
 Directive on consumer rights applies where an individual
purchases an app relating to health/ lifestyle/wellbeing
 Post Brexit, the E-Commerce Directive will continue to
apply to the UK for the duration of the transition period

52
52 Confidential
Access and reimbursement scenario- Germany
 In the past, only some telemedicine services were reimbursed by health insurance providers in Germany, significantly more so by
the private health insurance providers than by the public health insurance providers
 However, both numbers are increasing. Due to regulatory changes regarding telemedicine, the conditions for the reimbursement of
telemedicine services have changed accordingly, for example: – Video consultation hours are now not only reimbursed by the
private health insurance providers, but also by the public health insurance providers
 Content
 Telemedicine services are generally allowed, if they are used in
addition to personal contact
 Since legalization of remote treatment in 2018, it is also
permitted to provide medical advice or treatment exclusively
 The new Digital Healthcare Act which came into force in
January 2020, now allows physicians to inform about and
advertise telemedicine services on their website

53
53 Confidential
Access and reimbursement scenario- Italy
 The Italian Guidelines on Telemedicine expressly provide that, as for all the other medical activities, telemedicine tools can be
charged to the National Health Service (NHS)
 Both the public and private sector cover telemedicine services. In particular, as noted in the IVASS (Institute for Insurance
Supervision) report on the new health policies on digital health insurance dated October 2016, private health insurance covers many
telemedicine services
 Content
Sample

54
54 Confidential
Access and reimbursement scenario- Rest of EU
Sample
Sample

56
56 Confidential
Key Industry Developments
 Luscii was founded in 2018, and uses a mobile app to help prevent unnecessary hospital visits and admissions for
vulnerable patients by increasing access to clinical support and the improving the patient experience
 Luscii is now active in seven countries of EU and has secured worldwide partnerships with Apple and Omron
 Fifty per cent of Dutch hospitals are using Luscii and it has extended its services internationally (Ireland, Sweden, UK,
Netherlands
 The platform handled up to 15 Mn virtual care interactions between June and January 2020
 In light of the growing demand to shift medical care closer to home, Healthy.io launched the first direct-to-consumer UTI test
and treat service on May 5, 2020, called ‘Velieve’
 With Velieve, women can have a urinalysis kit delivered to their homes, use their smartphone to complete the test, have
results assessed by an online doctor, and, where indicated, have antibiotics delivered to their homes within hours
Content

57
57 Confidential
Future Opportunities
 Researchers with the EU-funded THALEA II project are pushing an innovative telemedicine system for Intensive Care Units
(ICUs) to market using a process called public procurement of innovative solutions. Assisted by ICT for Life, this project is
saving co-morbid patients in Europe as part of a Patient personalized care program of the EU
 Robotics is a promising cutting-edge and a futuristic tool in telemedicine that has potential applications in transforming
physical exam and clinical care, as well as monitoring patients in remote conditions
 The Society of European Robotic Gynecological Surgery has released guidelines for robot-assisted surgery (RAS) and
promoted the use of RAS over conventional laparoscopic and open surgery in managing infection risk
Content

59
59 Confidential
Conclusion
 Healthcare systems across EU are facing unprecedented pressure. While the quantity and quality of care has improved, the scale
and complexity of healthcare needs have grown, together with public expectations of more personalized and convenient services
 Telemedicine grew from less than 1% of primary care visits to nearly 43.5% in April 2020. With telemedicine’s current trajectory and
rapid adoption rate, it has the potential to disrupt and redefine the way health systems operate, deliver care and manage costs,
setting the stage for a vastly different healthcare experience in the future
 The end-goal of eHealth is the shift in the focus of healthcare provision from a doctor and hospital-centric approach to a patient and
wellness-centric focus, through the use of digital technologies
 With patients growing more accustomed to virtual care, health systems that lack telemedicine access will see decreased patient
volumes from patients choosing providers that do offer telemedicine
 The EC made a number of commitments to drive digital transformation like the development of EU-wide standards for data quality,
reliability and cybersecurity giving citizens secure access to a comprehensive electronic record of their personal health data
 The EC also highlighted the need to take account of emerging technologies such as blockchain, innovative identity management and
certification mechanisms. The technological advancements and a rising population would fuel the telemedicine market in the EU

EU Telemedicine Market Report

Recommended

Recommended

More Related Content

Similar to EU Telemedicine Market Report

Similar to EU Telemedicine Market Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

EU Telemedicine Market Report